REQUEST A DEMO
Total
USD $0.00
Search more companies

Optopol Technology Sp. z o.o. (Poland)

Main Activities: Medical Equipment and Supplies Manufacturing
Secondary Activities: Optical Instrument and Lens Manufacturing | Photographic and Photocopying Equipment Manufacturing | Navigational, Measuring, Electromedical, and Control Instruments Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Cosmetics, Beauty Supplies, and Perfume Stores | Other Publishers | Computer Systems Design and Related Services | Electronic and Precision Equipment Repair and Maintenance
Full name: Optopol Technology Sp. z o.o. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Optopol Technology Sp. z o.o. is a medical device manufacturer focused on ophthalmic diagnostic equipment, with product development centered on imaging and functional diagnostics platforms for professional eye care providers. The companys product portfolio includes spectral-domain optical coherence tomography (SD-OCT) devices and integrated imaging platforms, including the REVO FC family combining SD-OCT with a non-mydriatic color fundus camera, featuring hardware-based real-time eye tracking (AccuTrack) and high-speed scan performance (including 130,000 A-scans per second in the REVO FC 130). Product positioning highlights workflow efficiency, high-resolution OCT imaging and combined OCT plus true-color fundus documentation within a single device category, supported by distributor-based go-to-market structures. Optopol has also positioned its broader offering around automated perimeters and OCT-based solutions, with corporate development history including prior acquisition by Canon and subsequent re-acquisition by the founding family, followed by renewed product modernization and portfolio build-out. Geographic reach is supported through international distribution of ophthalmic diagnostic systems, with brand assets concentrated in the REVO product line and associated proprietary tracking and imaging features enabling differentiation in clinical workflow and diagnostic throughput. Strategic focus is aligned to innovation in ophthalmic diagnostics, modernization of OCT and perimeter solutions and expansion of global channel presence through differentiated imaging and automation capabilities.

Headquarters
Ul. Zabia 42
Zawiercie; Slaskie; Postal Code: 42-400

Contact Details: Purchase the Optopol Technology Sp. z o.o. report to view the information.

Website: http://www.optopol.com.pl

Basic Information
Total Employees:
Purchase the Optopol Technology Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Optopol Technology Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Optopol Technology Sp. z o.o. report to view the information.
Incorporation Date:
February 20, 2004
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
58.8%
Company Performance
Financial values in the chart are available after Optopol Technology Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
8.23%
Total operating revenue
7.63%
Operating Profit/Loss (EBIT)
-11.33%
EBITDA
-9.18%
Net Profit/Loss for the Period
-4.91%
Total Assets
10.56%
Total Equity
11.88%
Operating Profit Margin (ROS)
-3.88%
Net Profit Margin
-2.23%
Return on Equity (ROE)
-7.4%
Debt/Equity
1.23%
Quick Ratio
0.27%
Cash Ratio
-0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?